#MRNA VACCINE

Moderna and Merck report mRNA cancer vaccine reduces recurrence and death by forty-two percent

Pharmaceutical leaders Moderna and Merck released groundbreaking clinical trial data demonstrating that their investigational individualized mRNA cancer vaccine, when administered in combination with standard immunothera...

Moderna and Merck announce experimental mRNA cancer vaccine reduces recurrence and death by forty-two percent

In a momentous breakthrough for the emerging frontier of therapeutic oncology, pharmaceutical giants Moderna and Merck have publicly revealed clinical trial data showing that their investigational customized mRNA cancer ...